Recruiting Retinitis Pigmentosa Studies in Houston
A Phase 3 Study Of OCU400 Gene Therapy for the Treatment Of Retinitis Pigmentosa
This is a Phase 3 study to Assess the Efficacy, Safety and Tolerability of OCU400 in patients with retinitis pigmentosa (RP) associated with RHO mutations and patients with any other RP associated mut...
Study to Evaluate Ultevursen in Subjects With Retinitis Pigmentosa (RP) Due to Mutations in Exon 13 of the USH2A Gene
The purpose of this Phase 2b study is to evaluate the safety and tolerability of ultevursen administered via intravitreal injection (IVT) in subjects with Retinitis Pigmentosa (RP) due to mutations in...
About Retinitis Pigmentosa Clinical Trials in Houston
Retinitis pigmentosa (RP) is a group of inherited retinal diseases that cause progressive loss of photoreceptor cells in the retina, leading to vision loss. It typically begins with night blindness and progresses to tunnel vision. Gene therapy and retinal implants are areas of active research.
There are currently 2 retinitis pigmentosa clinical trials recruiting participants in Houston, TEXAS. These studies are seeking a combined 231 participants. Research is being sponsored by Ocugen, Laboratoires Thea. Clinical trial participation is free and participants receive study-related medical care at no cost.
Retinitis Pigmentosa Clinical Trials in Houston — FAQ
Are there retinitis pigmentosa clinical trials in Houston?
Yes, there are 2 retinitis pigmentosa clinical trials currently recruiting in Houston, TEXAS. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Houston?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Houston research site will contact you about next steps.
Are clinical trials in Houston free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Houston studies also compensate for your time and travel.
What retinitis pigmentosa treatments are being tested?
The 2 active trials in Houston are testing new therapies including novel drugs, biologics, and treatment approaches for retinitis pigmentosa.
Data updated March 2, 2026 from ClinicalTrials.gov